Dr. Schwartz, a board-certified gastroenterologist, has experience with more than 1,000 clinical trials in various specialties.
“Dr. Schwartz brings to the company a unique combination of medical practice and relevant commercial experience relating to specialty biologics that will add depth of knowledge to what is already a best-in-class contract commercial operations team,” said Stephen Cichy, founder and managing director of Monarch.
More articles on gastroenterology:
Dr. John Mitchell elected to BCBS of Nebraska board
Avantis Medical Systems submits 510(k) application for colonoscopy device
New guidelines suggest CRC patients undergo postoperative colonoscopy
